Sharekhan

BUY NOW Buy Dr Lalchandani Labs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Dr Lalchandani Labs Ltd

Thu 29/01/2026,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dr Lalchandani Labs Ltd

Your Vote -

Buy

25.00%

Hold

25.00%

Sell

50.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dr Lalchandani Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dr. Lalchandani Labs - Newspaper Publication Under Regulation 84(1) Of SEBI (ICDR) Regulations

    31 Jan 2026, 12:22PM Newspaper publication as per stated regulation

  • Dr. Lalchandani Labs - Letter Of Offer For Rights Issue Of Equity Shares

    21 Jan 2026, 10:52PM Please find enclosed the soft copy of Letter of Offer dated January 20, 2026, for the Rights Issue of Dr Lalchandani Labs Limited. The Company is also

  • Dr. Lalchandani Labs - Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requir

    20 Jan 2026, 8:46PM ntimation of Record Date pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Raising of Funds

    20 Jan 2026, 8:42PM In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that

  • Dr. Lalchandani Labs - Revised Outcome Of The Board Meeting Held On January 20, 2026 For Approving Terms Of Rights Issue

    20 Jan 2026, 8:39PM In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 20, 2026 For Approving Terms Of

    20 Jan 2026, 6:27PM In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that

  • Dr. Lalchandani Labs - Intimation Of In-Principle Approval

    16 Jan 2026, 8:56PM We are pleased to inform that the company has received the In-principle approval from BSE Limited for Rights issue of Equity Shares, the letter is enc

  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jan 2026, 7:14PM Compliance Certificate under Regulation 74(5) for Quarter ended December 31, 2025

  • Dr. Lalchandani Labs - Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Scheduled On December 22, 2025

    22 Dec 2025, 5:29PM This is with reference to our prior intimation dated December 16, 2025, wherein we had informed the Exchange about the meeting of the Board of Directo

  • Dr. Lalchandani Labs - Board Meeting Intimation for Fund Raising

    16 Dec 2025, 5:55PM Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2025 ,inter alia, to consider

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Raising of Funds

    15 Dec 2025, 5:21PM Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholders as on re

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of Board Meeting Held On December 15, 2025

    15 Dec 2025, 5:17PM Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 433.31 Lakhs, to t

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of Board Meeting

    9 Dec 2025, 6:06PM Outcome of Board Meeting

  • Dr. Lalchandani Labs - Board Meeting Intimation for Considering Of Raising Of Funds Through A Rights Issue And/Or Any Other P

    2 Dec 2025, 3:03PM Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2025 ,inter alia, to consider

  • Dr. Lalchandani Labs - Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 2025

    14 Nov 2025, 6:32PM Unaudited Financial Results for the half year ended September 2025

  • Dr. Lalchandani Labs - Unaudited Financials Results For The Half Year Ended September 30, 2025

    14 Nov 2025, 6:30PM Unaudited Financial results September 30, 2025

  • Dr. Lalchandani Labs - Board Meeting Intimation for Consider And Approve Financial Statements For The Half Year Ended 30.09.2

    10 Nov 2025, 5:27PM Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Dr Lalchandani Labs Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 14.0242 12.9424 13.6059 14.527 12.9481
Liabilities 14.0242 12.9424 13.6059 14.527 12.9481
Equity 4.3331 4.3331 4.3331 4.3331 4.333
Gross Profit 0.9233 0.1996 0.0834 2.406 2.2186
Net Profit 0.4172 0.6175 -1.5628 0.9333 1.0113
Cash From Operating Activities 0.3671 -0.218 -0.0013 2.0056 1.1879
NPM(%) 9.36 12.83 -31 8.27 10.34
Revenue 4.4538 4.8095 5.0402 11.2787 9.7799
Expenses 3.5305 4.6099 4.9568 8.8727 7.5613
ROE(%) 2.88 4.26 -10.78 6.44 6.98

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dr Lalchandani Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 709.00 2.46 0.00 10.03 301.39 0.70
Lotus Eye Hospital and Institute Ltd 130.90 -2.39 408.09 36.56 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.39 13.59 0.00 75.91 -39.50 0.00
Astec Lifesciences Ltd 590.85 2.86 0.00 34.48 -604.77 0.00

Company Info

The Company was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of Incorporation dated 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605.MAJOR EVENTS AND MILESTONES2017- Incorporation of the Company in the name and style of "Dr Lalchandani Labs Limited" to takeover the Existing Partnership Firm.- Entered into an Agreement for takeover of the Existing partership Firm named on going concern basis Dr A Lalchandani Pathology Laborataries2018- Entered in to an Agreement for purchase of acquiring office premises at J-23, Block-J, Lajpat Nagar-III, New Delhi for consideration other than cash from promoter, Mr. Arjan Lal Chandani.

The Company was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of Incorporation dated 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605.MAJOR EVENTS AND MILESTONES2017- Incorporation of the Company in the name and style of "Dr Lalchandani Labs Limited" to takeover the Existing Partnership Firm.- Entered into an Agreement for takeover of the Existing partership Firm named on going concern basis Dr A Lalchandani Pathology Laborataries2018- Entered in to an Agreement for purchase of acquiring office premises at J-23, Block-J, Lajpat Nagar-III, New Delhi for consideration other than cash from promoter, Mr. Arjan Lal Chandani.

Read More

Parent Organisation

Dr. Lalchandani Labs Ltd.

Founded

02/08/2017

Managing Director

Dr.Arjan Lal Chandani

NSE Symbol

FAQ

The current price of Dr Lalchandani Labs Ltd is

The 52-week high for Dr Lalchandani Labs Ltd is

The market capitalization of Dr Lalchandani Labs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dr Lalchandani Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dr Lalchandani Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dr Lalchandani Labs Ltd shares.

The CEO of Dr Lalchandani Labs Ltd is Dr.Arjan Lal Chandani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT